Dr. A, a US-trained molecular cell biologist working at the Qatar Ministry of Health, shared an incredible experience regarding her husband’s battle with Grade 2 Stage IV Lung Cancer. Diagnosed three months ago, his cancer had already spread to the lymph nodes and bones. With limited options, Dr. A was introduced to ECCT by an American friend in Qatar, though she initially expressed strong skepticism. "The data looked impressive," she said, "but it seemed too good to be true."
A博士是一位在卡塔尔卫生部工作的美国培训的分子细胞生物学家，她分享了关于她丈夫与四期肺癌抗争的非凡经历。三个月前，他被确诊时，癌症已经扩散到了淋巴结和骨骼。选择有限，A博士通过一位在卡塔尔工作的美国朋友了解到ECCT，但最初她表示非常怀疑。“数据看起来令人印象深刻，”她说，“但这似乎好得令人难以置信。”Her husband's cancer type was grade 2 adenocarcinoma, moderately differentiated, and EGFR mutation-negative. Due to the cancer's cell type, ECCT would provide a moderate response—neither too fast nor too slow—and that combining chemotherapy would help reduce inflammation and shrink the tumor more effectively.
她丈夫的癌症类型是二级腺癌，中度分化，并且EGFR基因突变为阴性。由于癌细胞类型的原因，ECCT将提供适度的反应——既不快也不慢——而且结合化疗将有助于更有效地减少炎症和缩小肿瘤。Still uncertain, Dr. A and her husband decided to proceed with ECCT, following the medical advice provided. His doctor in the US approved using the ECCT device while undergoing chemotherapy. After just 2.5 months of therapy, the results were astonishing. According to PET-CT scans, 80% of the cancer had disappeared, and the metastases in both his lymph nodes and bones were completely gone.
尽管仍然有些不确定，A博士和她的丈夫决定按照提供的医学建议继续使用ECCT。他在美国的医生允许他在接受化疗的同时使用ECCT设备。经过短短2.5个月的治疗，结果令人震惊。根据PET-CT扫描，80%的癌症已经消失，淋巴结和骨骼中的转移灶也完全消失了。Dr. A, once a skeptic, shared her joy: "His doctor in the US called it a miracle. We couldn’t believe the results." This journey from doubt to remarkable recovery stands as a powerful testament to the potential of combining ECCT with traditional treatment methods.
曾经怀疑的A博士分享了她的喜悦：“他在美国的医生称这是一场奇迹。我们无法相信这个结果。”从怀疑到显著康复的这段旅程，强有力地证明了将ECCT与传统治疗方法相结合的潜力。
Comments